Put Options

28 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $5.34 Million - $6.5 Million
32,600 Added 122.1%
59,300 $11.7 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $6.35 Million - $7.41 Million
-41,000 Reduced 60.56%
26,700 $4.58 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $13.2 Million - $15.1 Million
-82,900 Reduced 55.05%
67,700 $12.3 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $1.68 Million - $1.89 Million
12,200 Added 8.82%
150,600 $23.3 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $2.91 Million - $3.37 Million
21,800 Added 18.7%
138,400 $20.6 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $901,067 - $1.12 Million
6,800 Added 6.19%
116,600 $15.7 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $7.82 Million - $9.01 Million
-54,100 Reduced 33.01%
109,800 $17.5 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $23.3 Million - $28 Million
-168,700 Reduced 50.72%
163,900 $26.5 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $3.6 Million - $4.13 Million
-26,800 Reduced 7.46%
332,600 $44.6 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $11.1 Million - $14.1 Million
-80,400 Reduced 18.28%
359,400 $55 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $35.5 Million - $44 Million
-268,900 Reduced 37.94%
439,800 $71.3 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $10.6 Million - $13.4 Million
98,800 Added 16.2%
708,700 $96 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $48.1 Million - $54.7 Million
452,500 Added 287.48%
609,900 $65.8 Million
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $3.46 Million - $3.86 Million
-32,900 Reduced 17.29%
157,400 $17.7 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $53.1 Million - $58.5 Million
-519,068 Reduced 73.17%
190,300 $20.6 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $22.9 Million - $30.9 Million
-284,600 Reduced 28.63%
709,368 $76 Million
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $38.2 Million - $44.8 Million
-444,300 Reduced 30.89%
993,968 $87.1 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $68.1 Million - $91.1 Million
928,168 Added 181.96%
1,438,268 $141 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $10.2 Million - $15.5 Million
-158,700 Reduced 23.73%
510,100 $38.9 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $32.7 Million - $40.9 Million
453,200 Added 210.2%
668,800 $59.2 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $14.2 Million - $17.1 Million
-225,300 Reduced 51.1%
215,600 $16.3 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $16.7 Million - $21.3 Million
-254,100 Reduced 36.56%
440,900 $32.1 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $33.7 Million - $39.7 Million
436,900 Added 169.28%
695,000 $56 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $12.1 Million - $15 Million
-155,900 Reduced 37.66%
258,100 $23.8 Million
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $17.2 Million - $19.2 Million
194,000 Added 88.18%
414,000 $39.2 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $14.8 Million - $17.5 Million
165,000 Added 300.0%
220,000 $20.4 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $4.48 Million - $4.91 Million
50,000 Added 1000.0%
55,000 $5.32 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $349,250 - $446,100
5,000
5,000 $444,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.